These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 21726666)

  • 1. A locked nucleic acid clamp-mediated PCR assay for detection of a p53 codon 249 hotspot mutation in urine.
    Lin SY; Dhillon V; Jain S; Chang TT; Hu CT; Lin YJ; Chen SH; Chang KC; Song W; Yu L; Block TM; Su YH
    J Mol Diagn; 2011 Sep; 13(5):474-84. PubMed ID: 21726666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Codon 249 mutation in exon 7 of p53 gene in plasma DNA: maybe a new early diagnostic marker of hepatocellular carcinoma in Qidong risk area, China.
    Huang XH; Sun LH; Lu DD; Sun Y; Ma LJ; Zhang XR; Huang J; Yu L
    World J Gastroenterol; 2003 Apr; 9(4):692-5. PubMed ID: 12679912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P53 tumor suppressor gene mutations in hepatocellular carcinoma patients in India.
    Katiyar S; Dash BC; Thakur V; Guptan RC; Sarin SK; Das BC
    Cancer; 2000 Apr; 88(7):1565-73. PubMed ID: 10738214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-suppressor p53 gene in hepatitis C and B virus-associated human hepatocellular carcinoma.
    Shieh YS; Nguyen C; Vocal MV; Chu HW
    Int J Cancer; 1993 Jun; 54(4):558-62. PubMed ID: 8390407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational hotspot in the p53 gene in human hepatocellular carcinomas.
    Hsu IC; Metcalf RA; Sun T; Welsh JA; Wang NJ; Harris CC
    Nature; 1991 Apr; 350(6317):427-8. PubMed ID: 1849234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of low-level KRAS mutations using PNA-mediated asymmetric PCR clamping and melting curve analysis with unlabeled probes.
    Oh JE; Lim HS; An CH; Jeong EG; Han JY; Lee SH; Yoo NJ
    J Mol Diagn; 2010 Jul; 12(4):418-24. PubMed ID: 20413678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic aflatoxin B1-DNA adducts and TP53 mutations in patients with hepatocellular carcinoma despite low exposure to aflatoxin B1 in southern Japan.
    Shirabe K; Toshima T; Taketomi A; Taguchi K; Yoshizumi T; Uchiyama H; Harimoto N; Kajiyama K; Egashira A; Maehara Y
    Liver Int; 2011 Oct; 31(9):1366-72. PubMed ID: 21745313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low density DNA microarray for detection of most frequent TP53 missense point mutations.
    Rangel-López A; Maldonado-Rodríguez R; Salcedo-Vargas M; Espinosa-Lara JM; Méndez-Tenorio A; Beattie KL
    BMC Biotechnol; 2005 Feb; 5():8. PubMed ID: 15713227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation-Selected Amplification droplet digital PCR: A new single nucleotide variant detection assay for TP53
    Hu L; Ji YY; Zhu P; Lu RQ
    Anal Chim Acta; 2024 Aug; 1318():342929. PubMed ID: 39067934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coamplification at lower denaturation temperature-PCR increases mutation-detection selectivity of TaqMan-based real-time PCR.
    Li J; Wang L; Jänne PA; Makrigiorgos GM
    Clin Chem; 2009 Apr; 55(4):748-56. PubMed ID: 19233916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines.
    Hsu IC; Tokiwa T; Bennett W; Metcalf RA; Welsh JA; Sun T; Harris CC
    Carcinogenesis; 1993 May; 14(5):987-92. PubMed ID: 8389256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in the p53 tumor suppressor gene in tree shrew hepatocellular carcinoma associated with hepatitis B virus infection and intake of aflatoxin B1.
    Park US; Su JJ; Ban KC; Qin L; Lee EH; Lee YI
    Gene; 2000 Jun; 251(1):73-80. PubMed ID: 10863098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screen p53 mutations in hepatocellular carcinoma by FASAY: a novel splicing mutation.
    Wu XM; Fu JG; Ge WZ; Zhu JY; Wang JY; Zhang W; Qian W; Huo KK
    J Zhejiang Univ Sci B; 2007 Feb; 8(2):81-7. PubMed ID: 17266182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ser-249 p53 mutations in plasma DNA of patients with hepatocellular carcinoma from The Gambia.
    Kirk GD; Camus-Randon AM; Mendy M; Goedert JJ; Merle P; Trépo C; Bréchot C; Hainaut P; Montesano R
    J Natl Cancer Inst; 2000 Jan; 92(2):148-53. PubMed ID: 10639517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DMSO Increases Mutation Scanning Detection Sensitivity of High-Resolution Melting in Clinical Samples.
    Song C; Castellanos-Rizaldos E; Bejar R; Ebert BL; Makrigiorgos GM
    Clin Chem; 2015 Nov; 61(11):1354-62. PubMed ID: 26432802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations at codon 249 of p53 gene in human hepatocellular carcinomas from Tongan, China.
    Yang M; Zhou H; Kong RY; Fong WF; Ren LQ; Liao XH; Wang Y; Zhuang W; Yang S
    Mutat Res; 1997 Nov; 381(1):25-9. PubMed ID: 9403027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanism of hepatocarcinogenesis.
    Sheu JC
    J Gastroenterol Hepatol; 1997 Oct; 12(9-10):S309-13. PubMed ID: 9407351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [High resolution melting analysis for detecting p53 gene mutations in patients with non-small cell lung cancer].
    Chen Z; An S; Xie Z; Yan H; Chen J; Su J; Zhang X; Niu F; Guo W; Wu Y
    Zhongguo Fei Ai Za Zhi; 2011 Oct; 14(10):767-73. PubMed ID: 22008105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High resolution melting for mutation scanning of TP53 exons 5-8.
    Krypuy M; Ahmed AA; Etemadmoghadam D; Hyland SJ; ; DeFazio A; Fox SB; Brenton JD; Bowtell DD; Dobrovic A
    BMC Cancer; 2007 Aug; 7():168. PubMed ID: 17764544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B and alterations of the p53 tumor suppressor gene in hepatocellular carcinoma.
    Goldblum JR; Bartos RE; Carr KA; Frank TS
    Am J Surg Pathol; 1993 Dec; 17(12):1244-51. PubMed ID: 8238731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.